Aug 05, 2016 - Novo Nordisk A/S (NYSE:NVO)Q2 2016 Earnings CallAugust 05, 2016 7:00 am ETExecutivesLars Rebien Sørensen - President & Chief Executive OfficerMads Krogsgaard Thomsen - Chief Science Officer & Executiv
May 01, 2016 - Novo Nordisk A/S (NYSE:NVO) Q1 2016 Earnings Conference Call April 29, 2016, 07:00 ET Executives Lars Rebien Sorensen - CEO Mads Krogsgaard Thomsen - Chief Science Officer Jesper Brandgaard - CFO Jako
Feb 03, 2016 -
Sep 18, 2015 - 3M Safety and Graphics Business Group, a part of 3M Company (MMM), recently announced a minority equity investment in StrongArm Technologies Inc., - a company that designs innovative safety products.
Sep 17, 2015 - Novo Nordisk (NVO) announced that a head-to-head study comparing Victoza to Sanofi's Lyxumia for the treatment of type II diabetes met its primary endpoint.
Sep 09, 2015 - Novo Nordisk (NVO) Sees Hammer Chart Pattern: Time to Buy?
Sep 07, 2015 - Novartis' (NVS) Farydak (plus Velcade and dexamethasone) gets EU approval for relapsed and/or refractory multiple myeloma in treatment-experienced patients.
Sep 03, 2015 - Bristol-Myers Squibb Company (BMY) announced that the supplemental Biologics License Application for Opdivo has been accepted with priority review by the FDA.
Sep 03, 2015 - Novartis (NVS) launched Zarxio (biosimilar version of Amgen's Neupogen) in the U.S., which became the first FDA-approved biosimilar to be launched in the country.
Sep 02, 2015 - Bristol-Myers Squibb Company (BMY) and its partner AbbVie (ABBV) announced that the BLA for Empliciti has been accepted with priority review by the FDA.